Transdermal drug delivery system is a type of drug delivery system that delivers drugs through the skin. Transmucosal drug delivery system is a type of drug delivery system that delivers drugs through the mucous membrane. The global transdermal/transmucosal drug delivery systems market was valued at USD 3,890.2 million in 2018 and is expected to reach USD 7,907.5 million by 2030, growing at a CAGR of 10.6% from 2019 to 2030.
The global transdermal/transmucosal drug delivery systems market has been segmented on the basis of type into transdermal and transmucosal; on the basis of application into hospitals, clinics and others; and on the basis of region into North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA). In 2018, North America accounted for the largest share in terms of revenue generated from sales due to high adoption rates among patients suffering from chronic diseases such as diabetes mellitus or hypertension which require regular medication intake for long-term treatment purposes. The US, Canada and Mexico are some major countries in this region which have witnessed significant growth in this market over recent years due to increasing awareness about these devices among patients suffering from chronic diseases such as diabetes mellitus or hypertension which require regular medication intake for long-term treatment purposes.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases are driving the growth of the Transdermal/Transmucosal Drug Delivery System market.
- Increasing demand for pain relief drugs is also driving the growth of the Transdermal/Transmucosal Drug Delivery System market.
- The increasing number of new product launches in this segment is also driving the growth of this market.
- Growing awareness about transdermal drug delivery systems among consumers.
Industry Growth Insights published a new data on “Transdermal/Transmucosal Drug Delivery System Market”. The research report is titled “Transdermal/Transmucosal Drug Delivery System Market research by Types (Transdermal Drug Delivery System, Transmucosal Drug Delivery System, ), By Applications (Hospitals, Clinics, Others, ), By Players/Companies 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec, Mylan, Teva, Zosano Pharma”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal/Transmucosal Drug Delivery System Market Research Report
By Type
Transdermal Drug Delivery System, Transmucosal Drug Delivery System,
By Application
Hospitals, Clinics, Others,
By Companies
3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec, Mylan, Teva, Zosano Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal/Transmucosal Drug Delivery System Market Report Segments:
The global Transdermal/Transmucosal Drug Delivery System market is segmented on the basis of:
Types
Transdermal Drug Delivery System, Transmucosal Drug Delivery System,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Antares Pharma
- Aveva Drug Delivery Systems
- Corium International
- DURECT
- Pantec Biosolutions
- Tapemark
- Tesa Labtec
- Mylan
- Teva
- Zosano Pharma
Highlights of The Transdermal/Transmucosal Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transdermal Drug Delivery System
- Transmucosal Drug Delivery System
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal/Transmucosal Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transdermal/transmucosal drug delivery system (TDD) is a device that delivers drugs to the skin or mucosa by way of the bloodstream.
Some of the major companies in the transdermal/transmucosal drug delivery system market are 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec, Mylan, Teva, Zosano Pharma.
The transdermal/transmucosal drug delivery system market is expected to register a CAGR of 10.6%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transdermal/Transmucosal Drug Delivery System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transdermal/Transmucosal Drug Delivery System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transdermal/Transmucosal Drug Delivery System Market - Supply Chain
4.5. Global Transdermal/Transmucosal Drug Delivery System Market Forecast
4.5.1. Transdermal/Transmucosal Drug Delivery System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transdermal/Transmucosal Drug Delivery System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transdermal/Transmucosal Drug Delivery System Market Absolute $ Opportunity
5. Global Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Type
5.3.1. Transdermal Drug Delivery System
5.3.2. Transmucosal Drug Delivery System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transdermal/Transmucosal Drug Delivery System Demand Share Forecast, 2019-2026
9. North America Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Type
9.7.1. Transdermal Drug Delivery System
9.7.2. Transmucosal Drug Delivery System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transdermal/Transmucosal Drug Delivery System Demand Share Forecast, 2019-2026
10. Latin America Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Type
10.7.1. Transdermal Drug Delivery System
10.7.2. Transmucosal Drug Delivery System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transdermal/Transmucosal Drug Delivery System Demand Share Forecast, 2019-2026
11. Europe Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transdermal/Transmucosal Drug Delivery System Market Size an Volume Forecast by Type
11.7.1. Transdermal Drug Delivery System
11.7.2. Transmucosal Drug Delivery System
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transdermal/Transmucosal Drug Delivery System Demand Share, 2019-2026
12. Asia Pacific Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Type
12.7.1. Transdermal Drug Delivery System
12.7.2. Transmucosal Drug Delivery System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transdermal/Transmucosal Drug Delivery System Demand Share, 2019-2026
13. Middle East & Africa Transdermal/Transmucosal Drug Delivery System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transdermal/Transmucosal Drug Delivery System Market Size and Volume Forecast by Type
13.7.1. Transdermal Drug Delivery System
13.7.2. Transmucosal Drug Delivery System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transdermal/Transmucosal Drug Delivery System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transdermal/Transmucosal Drug Delivery System Market: Market Share Analysis
14.2. Transdermal/Transmucosal Drug Delivery System Distributors and Customers
14.3. Transdermal/Transmucosal Drug Delivery System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Antares Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aveva Drug Delivery Systems
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Corium International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. DURECT
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pantec Biosolutions
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Tapemark
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Tesa Labtec
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mylan
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Teva
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Zosano Pharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
